MEDP vs WAT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 28, 2026
MEDP
WAT
Investment Advisor Scores
WAT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MEDP | WAT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 31.6456 | 26.178 | WAT |
| PEG Ratio | 3.2688 | 1.6796 | WAT |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 17.2% | 91.4% | WAT |
| Earnings Growth | 37.1% | -3.1% | MEDP |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.6/100 | 47.6/100 | MEDP |
| Profit Margin | 17.7% | 11.9% | MEDP |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MEDP
MarkupPrice above SMA50, rising 50-day trend (12.0% over 20 days), RSI 60
WAT
MarkupPrice above SMA50, rising 50-day trend (5.5% over 20 days), RSI 52
Fundamentals Snapshot
| Metric | MEDP | WAT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 29.7 | 22.7 |
| Trailing P/E | 33.9 | 48.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.9% |
| Gross Margin | 0.7% | 0.6% |
| Operating Margin | 0.2% | 0.0% |
| EPS | 17.01 | 7.85 |
| Dividend Yield | — | — |